US · AFJK
Aimei Health Technology Co., Ltd
- Sector
- Financial Services · Shell Companies
- Headquarters
- New York City, NY 10022
Price · as of 2024-12-31
$46.18
Market cap 197.79M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | $10.18 | ||||
| 2024 | $10.95 |
AI valuation
Our deep-learning model estimates Aimei Health Technology Co., Ltd's (AFJK) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- $46.18
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| AFJK | Aimei Health Technology C… | $46.18 | 197.79M | — | — | — | — | 38.73 | 1.37 | — | -92.99 | 2.82 | 1.37 | 0.00% | — | — | 3.59% | -1.50% | 3.54% | 0.00 | — | 0.04 | 0.03 | -0.19 | 137368.00% | — | — | -0.68% | -0.82 | -0.95% | 0.00% | 0.00% | 0.00% | -92.99 | -147.31 | — | 39.26 |
| BAYA | Bayview Acquisition Corp … | $11.85 | 64.48M | — | — | — | — | 44.48 | 2.15 | — | -76.31 | 2.16 | 2.15 | 0.00% | — | — | 3.70% | -2.17% | 3.49% | 0.01 | — | 0.10 | 0.07 | -0.40 | 206216.00% | — | 1098136.00% | -0.63% | -0.38 | -1.03% | 0.00% | 0.00% | 30.53% | -76.31 | -160.39 | — | 13.60 |
| CPBI | Central Plains Bancshares… | $17.77 | 74.73M | +399% | -18% | +50% | +19% | 15.50 | 0.68 | 2.07 | -5.34 | — | 0.68 | 69.19% | 16.56% | 13.38% | 4.52% | 10.49% | 0.75% | 0.00 | 0.55 | — | — | -6.34 | -1233.00% | 1468.00% | -18950.00% | -5.42% | — | -8.81% | 0.00% | 0.00% | 31.68% | -5.34 | 7.88 | -0.88 | 0.30 |
| EURK | Eureka Acquisition Corp C… | $11.10 | 84.87M | — | — | — | — | 39.96 | -87.60 | — | -63.65 | — | -87.60 | 0.00% | — | — | 4.71% | -2.99% | 3.04% | 0.00 | — | 0.14 | 0.07 | 0.06 | -141343.00% | — | 13678.00% | -1.22% | -0.92 | -2.33% | 0.00% | 0.00% | 0.00% | -63.65 | -81.81 | — | 45.22 |
| UYSC | UY Scuti Acquisition Corp… | $10.31 | 78.96M | — | — | — | — | -0.08 | -0.09 | — | 0.03 | -0.01 | -0.09 | 0.00% | — | — | 260.83% | 228.10% | -95.06% | 0.00 | — | 0.05 | 0.05 | 0.11 | 100000.00% | — | — | -1626.98% | -0.54 | 296.97% | 0.00% | 0.00% | 137.49% | 0.03 | 0.02 | — | -4.90 |
About Aimei Health Technology Co., Ltd
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
- CEO
- Junheng Xie
- Employees
- 2
- Beta
- -3.70
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $46.18) − 1 = — (DCF, example).